Investors following the U.S. infrastructure and construction space often weigh pure-play specialty contractors against larger, more diversified builders. ECG (Everus Construction Group) and MTZ (MasTec, Inc.) both stand to benefit from data center and electric grid expansion, yet they carry very different risk profiles. This comparison matters for traders assessing relative performance and for longer-term investors considering a focused high-growth contractor versus a broader infrastructure platform. Recent market pressure on both stocks makes a direct look at fundamentals, momentum, and sentiment especially relevant.
ECG, Everus Construction Group, works through two main segments: Electrical & Mechanical and Transmission & Distribution. After spinning off from MDU Resources late last year, it has emerged as a pure-play name tied to data center construction, power grid upgrades, and AI-related infrastructure needs. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Financial results for the first nine months of 2026 showed operating revenues up 33.6% year over year to about $3.65 billion, with net income rising roughly 59.8% to $234.1 million. Backlog reached $5.48 billion, nearly double the prior year’s $2.95 billion, while non-GAAP EBITDA margin improved to 9.8% from 8.6%.
The stock has still seen volatility. It has pulled back from a 52-week high near $171.58 and now trades in the low $80s, down more than 30% over three months with a sharp move lower in early November. Acquisitions such as SE&M and Epsilon for $295 million, along with a refinanced credit facility, have broadened its reach, though sector-wide swings have affected sentiment.
MTZ, MasTec, Inc., is a larger infrastructure engineering and construction firm founded in 1929 and based in Coral Gables, Florida, with around 42,000 employees. It operates in five segments—Communications, Clean Energy and Infrastructure, Power Delivery, Pipeline Infrastructure, and Other—serving wireless providers, renewable developers, utilities, and pipeline operators. Trailing-twelve-month revenue is near $17.3 billion, highlighting its greater scale compared with ECG.
Recent price action has been weaker. MTZ has fallen from a 52-week high near $441.43 in May 2026 to the mid-$160s, a drop of roughly 40% over three months, with a beta near 1.92 indicating above-average volatility. Sell-side consensus remains a Strong Buy with an average price target near $301, suggesting analysts see the pullback as temporary relative to long-term backlog and demand. Higher leverage, with debt-to-equity above 100%, and sector profit-taking have contributed to the move lower.
The main difference lies in concentration versus diversification. ECG offers direct exposure with a backlog that has nearly doubled and solid double-digit revenue growth, yet its smaller market capitalization of around $4.4 billion and narrower customer base leave it more exposed to any single project or market shift. MTZ spreads risk across five segments and a roughly $13–14 billion market cap but carries higher leverage and has seen a deeper price decline.
Both companies ride the same secular trends in data centers, grid modernization, and clean energy, though ECG is more tightly aligned with those themes. On the risk side, MTZ’s debt load and beta add financial and market sensitivity, while ECG’s concentration and shorter public track record bring their own uncertainties. Both stocks currently sit below longer-term moving averages, reflecting cautious sentiment across the sector.
Based on current observable factors, Tickeron’s AI would likely favor ECG over MTZ. The edge comes from more consistent fundamental momentum: accelerating revenue, expanding profitability, and a backlog that has nearly doubled year over year. These elements tend to support trend durability even in volatile periods. While MTZ enjoys strong analyst support and greater scale, its steeper drawdown, higher leverage, and less uniform earnings picture add comparatively more uncertainty. This view is probabilistic and draws from historical patterns; it is not a forecast of future returns.
One tool I’ve found helpful for this kind of analysis is Tickeron’s AI Trading Bots. It lets me review automated strategies that align with current volatility and momentum conditions, adding a systematic layer to the fundamental review without replacing it.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MTZ declined for three days, in 221 of 284 cases, the price declined further within the following month. The odds of a continued downward trend are 78%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MTZ as a result. In 57 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for MTZ turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 37 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
The Aroon Indicator for MTZ entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for MTZ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +18.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTZ advanced for three days, in 278 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
MTZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.021) is normal, around the industry mean (15.143). P/E Ratio (27.461) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (0.616) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.215) among similar stocks. P/S Ratio (1.103) is also within normal values, averaging (2.886).
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. MTZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a infrastructure construction company
Industry EngineeringConstruction